INR 117.5
(-1.26%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 52.46 Million INR | 127.71% |
2022 | 23.04 Million INR | -60.6% |
2021 | 58.47 Million INR | 2945.52% |
2020 | 1.92 Million INR | -53.32% |
2019 | 4.11 Million INR | -75.32% |
2018 | 16.66 Million INR | -72.12% |
2017 | 59.77 Million INR | -44.24% |
2016 | 107.19 Million INR | -55.76% |
2015 | 242.3 Million INR | -15.19% |
2014 | 285.71 Million INR | 41.08% |
2013 | 202.52 Million INR | 42.19% |
2012 | 142.42 Million INR | 35.48% |
2011 | 105.12 Million INR | 11.85% |
2010 | 93.98 Million INR | 16.27% |
2009 | 80.83 Million INR | -45.89% |
2008 | 149.38 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 Q4 | 52.46 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q2 | 15.6 Million INR | 0.0% |
2023 FY | 52.46 Million INR | 127.71% |
2022 Q1 | - INR | -100.0% |
2022 Q2 | 139.09 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 FY | 23.04 Million INR | -60.6% |
2022 Q4 | 23.04 Million INR | 0.0% |
2021 Q4 | 58.47 Million INR | 0.0% |
2021 FY | 58.47 Million INR | 2945.52% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 55.4 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2020 FY | 1.92 Million INR | -53.32% |
2020 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2020 Q2 | 755 Thousand INR | 0.0% |
2020 Q4 | 1.92 Million INR | 0.0% |
2019 FY | 4.11 Million INR | -75.32% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 4.11 Million INR | 0.0% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 3.03 Million INR | 0.0% |
2018 Q4 | 16.66 Million INR | 0.0% |
2018 FY | 16.66 Million INR | -72.12% |
2018 Q1 | - INR | 0.0% |
2017 FY | 59.77 Million INR | -44.24% |
2016 FY | 107.19 Million INR | -55.76% |
2015 Q2 | 191.71 Million INR | 0.0% |
2015 FY | 242.3 Million INR | -15.19% |
2014 Q1 | - INR | -100.0% |
2014 FY | 285.71 Million INR | 41.08% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 210.07 Million INR | 0.0% |
2014 Q4 | 285.71 Million INR | 0.0% |
2013 Q1 | - INR | -100.0% |
2013 FY | 202.52 Million INR | 42.19% |
2013 Q3 | - INR | -100.0% |
2013 Q2 | 217.86 Million INR | 0.0% |
2013 Q4 | 202.52 Million INR | 0.0% |
2012 FY | 142.42 Million INR | 35.48% |
2012 Q4 | 142.42 Million INR | 0.0% |
2011 FY | 105.12 Million INR | 11.85% |
2011 Q4 | 105.12 Million INR | 0.0% |
2010 FY | 93.98 Million INR | 16.27% |
2009 FY | 80.83 Million INR | -45.89% |
2008 FY | 149.38 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Ajanta Pharma Limited | 352.8 Million INR | 85.129% |
Amrutanjan Health Care Limited | 17.28 Million INR | -203.564% |
Sigachi Industries Limited | 1.43 Billion INR | 96.332% |
Bal Pharma Limited | 1.39 Billion INR | 96.243% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 68.436% |
Medico Remedies Limited | 80.5 Million INR | 34.829% |
Lasa Supergenerics Limited | 220.76 Million INR | 76.235% |
Venus Remedies Limited | 413.3 Million INR | 87.306% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 91.42% |
Nectar Lifesciences Limited | 6.35 Billion INR | 99.174% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.44% |
Aarti Drugs Limited | 5.64 Billion INR | 99.07% |
Lupin Limited | 29.21 Billion INR | 99.82% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.921% |
Zydus Lifesciences Limited | 8.04 Billion INR | 99.348% |
Windlas Biotech Limited | 36.41 Million INR | -44.095% |
Suven Life Sciences Limited | 7.09 Million INR | -639.256% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.811% |
Valiant Laboratories Limited | 767.08 Million INR | 93.16% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 98.611% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.481% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.635% |
Bliss GVS Pharma Limited | 998.4 Million INR | 94.745% |
Achyut Healthcare Limited | - INR | -Infinity% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.84% |
Bajaj HealthCare Limited | 3.32 Billion INR | 98.424% |
RPG Life Sciences Limited | - INR | -Infinity% |
Mankind Pharma Limited | 2.07 Billion INR | 97.468% |
Laurus Labs Limited | 25.77 Billion INR | 99.796% |
Piramal Pharma Limited | 47.1 Billion INR | 99.889% |
Syncom Formulations (India) Limited | 724.86 Million INR | 92.762% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.87% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 98.978% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.574% |
Unichem Laboratories Limited | 2.47 Billion INR | 97.88% |
Sequent Scientific Limited | 4.87 Billion INR | 98.924% |
Novartis India Limited | 69.7 Million INR | 24.727% |
Wanbury Limited | 1.16 Billion INR | 95.496% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 91.928% |
Wockhardt Limited | 23.56 Billion INR | 99.777% |
Themis Medicare Limited | 957.92 Million INR | 94.523% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 41.321% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.857% |
Glenmark Life Sciences Limited | 171.48 Million INR | 69.405% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.738% |
Divi's Laboratories Limited | 30 Million INR | -74.883% |
NATCO Pharma Limited | 3.71 Billion INR | 98.587% |
Gufic Biosciences Limited | 3.32 Billion INR | 98.424% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 83.985% |
Ind-Swift Limited | 10.13 Billion INR | 99.483% |
Procter & Gamble Health Limited | 95.6 Million INR | 45.12% |
FDC Limited | 205.18 Million INR | 74.43% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 97.288% |
Granules India Limited | 13.15 Billion INR | 99.601% |
Medicamen Biotech Limited | 308.17 Million INR | 82.975% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.63% |
AstraZeneca Pharma India Limited | 45.98 Million INR | -14.099% |
Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -1095.375% |
Brooks Laboratories Limited | 56.41 Million INR | 7.008% |
Megasoft Limited | 1.47 Billion INR | 96.432% |
ZIM Laboratories Limited | 1.08 Billion INR | 95.179% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.792% |
Neuland Laboratories Limited | 953.89 Million INR | 94.5% |
Morepen Laboratories Limited | 289.99 Million INR | 81.908% |
Hikal Limited | 8.17 Billion INR | 99.358% |
Indoco Remedies Limited | 6.71 Billion INR | 99.219% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 98.161% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 83.422% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 94.673% |
Hester Biosciences Limited | 2.44 Billion INR | 97.853% |